Chell Jeffrey W.

CIK 00017383741 companyNEW YORK,, NY

Transactions

Companies

Filings

CIK

0001738374

Recent Transactions

13 trades

Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−2,500→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−8,333→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−18,351→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−72,156→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−2,500→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−8,333→ 0 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−70,311→ 0 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2023-12-28+70,311→ 70,311 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2022-07-01+72,156→ 72,156 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2021-09-01+18,351→ 18,351 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2020-08-12+8,333→ 8,333 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Options to purchase common stock
2019-07-12$0.23/sh+250,000→ 250,000 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Options to purchase common stock
2018-07-13$0.78/sh+75,000→ 75,000 total

C/O ACTINIUM PHARMACEUTICALS, INC., 100 PARK AVE., 23RD FLOOR

NEW YORK,, NY, 10017